Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 3679 | Biofrontera Inc.NASDAQ: BFRI | Life Sciences | $10.2M | 3 | Financial ResultsNov 13, 2026 |
| 3682 | Cellectar Biosciences, Inc.NASDAQ: CLRB | Life Sciences | $10.1M | 2 | Financial ResultsNov 10, 2026 |
| 3684 | Intensity Therapeutics, Inc.NASDAQ: INTS | Life Sciences | $10.1M | 3 | Earnings CallNov 5, 2026 |
| 3688 | Brainstorm Cell Therapeutics Inc.OTC: BCLI | Life Sciences | $9.93M | 2 | Financial ResultsNov 16, 2026 |
| 3703 | BullFrog AI Holdings, Inc.NASDAQ: BFRG | Life Sciences | $9.12M | 1 | Financial ResultsNov 13, 2026 |
| 3706 | Phio Pharmaceuticals Corp.NASDAQ: PHIO | Life Sciences | $8.99M | 8 | Insider BuyingNov 10, 2026 |
| 3710 | In8Bio, Inc.NASDAQ: INAB | Life Sciences | $8.82M | 2 | Financial ResultsNov 5, 2026 |
| 3721 | Vistagen Therapeutics, Inc.NASDAQ: VTGN | Life Sciences | $8.51M | 8 | Financial ResultsNov 13, 2026 |
| 3733 | CalciMedica, Inc.NASDAQ: CALC | Life Sciences | $8.21M | 5 | Financial ResultsNov 10, 2026 |
| 3736 | MetaVia Inc.NASDAQ: MTVA | Life Sciences | $8.13M | 8 | Clinical Trial DataNov 17, 2026 |
| 3737 | FibroBiologics, Inc.NASDAQ: FBLG | Life Sciences | $8.12M | 3 | Loan & DebtOct 8, 2026 |
| 3742 | Rocket One Inc.NASDAQ: RKTO | Life Sciences | $7.99M | 3 | Financial ResultsNov 13, 2026 |
| 3745 | Ensysce Biosciences, Inc.NASDAQ: ENSC | Life Sciences | $7.97M | 5 | Financial ResultsNov 12, 2026 |
| 3752 | Moleculin Biotech, Inc.NASDAQ: MBRX | Life Sciences | $7.58M | 16 | Financial ResultsNov 16, 2026 |
| 3753 | GT Biopharma, Inc.NASDAQ: GTBP | Life Sciences | $7.56M | 4 | Financial ResultsNov 16, 2026 |
| 3763 | Curanex Pharmaceuticals IncNASDAQ: CURX | Life Sciences | $7.27M | 2 | Financial ResultsNov 13, 2026 |
| 3764 | Mannatech IncNASDAQ: MTEX | Life Sciences | $7.26M | 5 | Financial ResultsNov 12, 2026 |
| 3765 | Volitionrx LtdNYSE: VNRX | Life Sciences | $7.21M | 7 | Financial ResultsNov 12, 2026 |
| 3774 | Tempest Therapeutics, Inc.NASDAQ: TPST | Life Sciences | $6.83M | 12 | Financial ResultsNov 13, 2026 |
| 3775 | Exicure, Inc.NASDAQ: XCUR | Life Sciences | $6.82M | 2 | DivestitureNov 10, 2026 |
| 3779 | Soligenix, Inc.NASDAQ: SNGX | Life Sciences | $6.73M | 2 | Financial ResultsNov 6, 2026 |
| 3793 | Enveric Biosciences, Inc.NASDAQ: ENVB | Life Sciences | $6.45M | 2 | Financial ResultsNov 13, 2026 |
| 3795 | Theriva Biologics, Inc.NYSE: TOVX | Life Sciences | $6.42M | 3 | Financial ResultsNov 12, 2026 |
| 3806 | Zeo ScientifiX, Inc.OTC: ZEOX | Life Sciences | $6.24M | 6 | Business UpdateNov 3, 2026 |
| 3807 | Oncotelic Therapeutics, Inc.OTC: OTLC | Life Sciences | $6.13M | 4 | Financial ResultsNov 16, 2026 |
| 3809 | Biomerica IncNASDAQ: BMRA | Life Sciences | $6.07M | 2 | Financial ResultsOct 15, 2026 |
| 3824 | Aprea Therapeutics, Inc.NASDAQ: APRE | Life Sciences | $5.77M | 2 | Financial ResultsNov 4, 2026 |
| 3826 | Alzamend Neuro, Inc.NASDAQ: ALZN | Life Sciences | $5.69M | 2 | Capital RaiseNov 10, 2026 |
| 3828 | Acurx Pharmaceuticals, Inc.NASDAQ: ACXP | Life Sciences | $5.66M | 3 | Leadership ChangeNov 13, 2026 |
| 3838 | Scienture Holdings, Inc.NASDAQ: SCNX | Life Sciences | $5.35M | 5 | Financial ResultsNov 16, 2026 |
| 3839 | Cardio Diagnostics Holdings, Inc.NASDAQ: CDIO | Life Sciences | $5.3M | 2 | Financial ResultsNov 6, 2026 |
| 3843 | AIM ImmunoTech Inc.NYSE: AIM | Life Sciences | $5.23M | 3 | Financial ResultsNov 12, 2026 |
| 3844 | CNS Pharmaceuticals, Inc.NASDAQ: CNSP | Life Sciences | $5.14M | 2 | Financial ResultsNov 16, 2026 |
| 3847 | Cadrenal Therapeutics, Inc.NASDAQ: CVKD | Life Sciences | $4.99M | 2 | Other 8-K FilingOct 7, 2026 |
| 3851 | Lantern Pharma Inc.NASDAQ: LTRN | Life Sciences | $4.97M | 4 | Nasdaq/NYSE Compliance NoticeOct 1, 2026 |
| 3854 | Pulmatrix, Inc.NASDAQ: PULM | Life Sciences | $4.86M | 2 | M&A DealNov 17, 2026 |
| 3855 | Integrated Biopharma IncOTC: INBP | Life Sciences | $4.81M | 3 | Financial ResultsNov 13, 2026 |
| 3856 | Processa Pharmaceuticals, Inc.NASDAQ: PCSA | Life Sciences | $4.81M | 5 | Financial ResultsNov 13, 2026 |
| 3860 | Skye Bioscience, Inc.NASDAQ: SKYE | Life Sciences | $4.71M | 6 | Financial ResultsNov 13, 2026 |
| 3874 | Kiora Pharmaceuticals IncNASDAQ: KPRX | Life Sciences | $4.34M | 3 | Financial ResultsNov 12, 2026 |
| 3881 | Curis IncNASDAQ: CRIS | Life Sciences | $4.15M | 4 | Financial ResultsNov 13, 2026 |
| 3887 | Alaunos Therapeutics, Inc.NASDAQ: TCRT | Life Sciences | $4.06M | 6 | Financial ResultsNov 16, 2026 |
| 3891 | Traws Pharma, Inc.NASDAQ: TRAW | Life Sciences | $4M | 3 | Financial ResultsNov 16, 2026 |
| 3894 | Creative Medical Technology Holdings, Inc.NASDAQ: CELZ | Life Sciences | $3.95M | 3 | Nasdaq/NYSE Compliance NoticeNov 13, 2026 |
| 3895 | Reviva Pharmaceuticals Holdings, Inc.OTC: RVPH | Life Sciences | $3.93M | 2 | Financial ResultsNov 13, 2026 |
| 3898 | Imunon, Inc.NASDAQ: IMNN | Life Sciences | $3.85M | 5 | Financial ResultsNov 12, 2026 |
| 3903 | Azitra, Inc.NYSE: AZTR | Life Sciences | $3.8M | 8 | Financial ResultsNov 12, 2026 |
| 3904 | Apimeds Pharmaceuticals US, Inc.NYSE: APUS | Life Sciences | $3.77M | 5 | Financial ResultsNov 16, 2026 |
| 3910 | Polomar Health Services, Inc.OTC: PMHS | Life Sciences | $3.55M | 4 | Financial ResultsNov 16, 2026 |
| 3913 | Xenetic Biosciences, Inc.NASDAQ: XBIO | Life Sciences | $3.49M | 4 | M&A DealNov 13, 2026 |
| 3920 | Silo Pharma, Inc.NASDAQ: SILO | Life Sciences | $3.4M | 4 | Financial ResultsNov 13, 2026 |
| 3922 | Ctt Pharmaceutical Holdings, Inc.OTC: CTTH | Life Sciences | $3.34M | 2 | Other 8-K FilingOct 30, 2026 |
| 3927 | Medicus Pharma Ltd.NASDAQ: MDCX | Life Sciences | $3.25M | 7 | Capital RaiseNov 16, 2026 |
| 3937 | GRI Bio, Inc.NASDAQ: GRI | Life Sciences | $3.06M | 2 | Financial ResultsNov 13, 2026 |
| 3943 | Aibotics, Inc.OTC: AIBT | Life Sciences | $2.98M | 2 | M&A DealOct 16, 2026 |
| 3944 | Dermata Therapeutics, Inc.NASDAQ: DRMA | Life Sciences | $2.95M | 4 | Business UpdateNov 17, 2026 |
| 3946 | Ernexa Therapeutics Inc.NASDAQ: ERNA | Life Sciences | $2.86M | 4 | Financial ResultsNov 6, 2026 |
| 3955 | Q/C Technologies, Inc.NASDAQ: QCLS | Life Sciences | $2.77M | 3 | Financial ResultsNov 16, 2026 |
| 3962 | Bioxytran, IncOTC: BIXT | Life Sciences | $2.64M | 2 | Product LaunchNov 16, 2026 |
| 3963 | Revelation Biosciences, Inc.NASDAQ: REVB | Life Sciences | $2.61M | 1 | Financial ResultsNov 5, 2026 |
| 3968 | Genprex, Inc.NASDAQ: GNPX | Life Sciences | $2.54M | 5 | Financial ResultsNov 13, 2026 |
| 3969 | HCW Biologics Inc.NASDAQ: HCWB | Life Sciences | $2.51M | 4 | Financial ResultsNov 16, 2026 |
| 3970 | VivoSim Labs, INC.NASDAQ: VIVS | Life Sciences | $2.51M | 3 | Financial ResultsNov 12, 2026 |
| 3979 | CDT Equity Inc.NASDAQ: CDT | Life Sciences | $2.38M | 8 | Financial ResultsNov 16, 2026 |
| 3981 | CV Sciences, Inc.OTC: CVSI | Life Sciences | $2.32M | 4 | Insider BuyingNov 16, 2026 |
| 3987 | 60 Degrees Pharmaceuticals, Inc.NASDAQ: SXTP | Life Sciences | $2.21M | 6 | Financial ResultsNov 16, 2026 |
| 3991 | Decoy Therapeutics Inc.NASDAQ: DCOY | Life Sciences | $2.15M | 3 | Financial ResultsNov 12, 2026 |
| 3995 | Sunshine Biopharma Inc.NASDAQ: SBFM | Life Sciences | $2.14M | 5 | Financial ResultsNov 12, 2026 |
| 3998 | Calidi Biotherapeutics, Inc.NYSE: CLDI | Life Sciences | $2.08M | 4 | Financial ResultsNov 13, 2026 |
| 4010 | Pmgc Holdings Inc.NASDAQ: ELAB | Life Sciences | $1.94M | 5 | Financial ResultsNov 13, 2026 |
| 4014 | Kairos Pharma, LTD.NYSE: KAPA | Life Sciences | $1.91M | 4 | Financial ResultsNov 13, 2026 |
| 4016 | Aptevo Therapeutics Inc.NASDAQ: APVO | Life Sciences | $1.9M | 11 | Financial ResultsNov 16, 2026 |
| 4030 | Lftd Partners Inc.OTC: LIFD | Life Sciences | $1.63M | 2 | Financial ResultsNov 13, 2026 |
| 4033 | Artelo Biosciences, Inc.NASDAQ: ARTL | Life Sciences | $1.59M | 2 | Financial ResultsNov 12, 2026 |
| 4047 | Agentix Corp.OTC: AGTX | Life Sciences | $1.35M | 1 | Financial ResultsNov 6, 2026 |
| 4051 | Nexentis Technologies Inc.NASDAQ: NXTS | Life Sciences | $1.33M | 5 | Financial ResultsNov 16, 2026 |
| 4063 | Silexion Therapeutics CorpNASDAQ: SLXN | Life Sciences | $1.14M | 9 | Financial ResultsNov 16, 2026 |
| 4069 | GeoVax Labs, Inc.NASDAQ: GOVX | Life Sciences | $1.1M | 6 | Financial ResultsNov 12, 2026 |
| 4075 | Skinvisible, Inc.OTC: SKVI | Life Sciences | $973K | 1 | Financial ResultsNov 16, 2026 |
| 4082 | Oragenics IncNYSE: OGEN | Life Sciences | $893K | 2 | Financial ResultsNov 12, 2026 |
| 4085 | Avenue Therapeutics, Inc.OTC: ATXI | Life Sciences | $847K | 1 | Financial ResultsNov 6, 2026 |
| 4087 | Lunai Bioworks Inc.NASDAQ: LNAI | Life Sciences | $830K | 4 | Executive CompensationNov 12, 2026 |
| 4089 | ProtoKinetix, Inc.OTC: PKTX | Life Sciences | $823K | 1 | Financial ResultsNov 4, 2026 |
| 4090 | Protagenic Therapeutics, Inc.\newOTC: PTIX | Life Sciences | $815K | 2 | Financial ResultsNov 6, 2026 |
| 4091 | Trafalgar International, Inc.OTC: TRFA | Life Sciences | $805K | 2 | Other 8-K FilingOct 14, 2026 |
| 4093 | Evofem Biosciences, Inc.OTC: EVFM | Life Sciences | $795K | 4 | Financial ResultsNov 13, 2026 |
| 4105 | Karyopharm Therapeutics Inc.NASDAQ: KPTIQ | Life Sciences | $649K | 5 | Bankruptcy & RestructuringNov 3, 2026 |
| 4114 | Lakewood-Amedex Biotherapeutics Inc.NASDAQ: LABT | Life Sciences | $520K | 3 | Nasdaq/NYSE Compliance NoticeNov 16, 2026 |
| 4127 | BioXcel Therapeutics, Inc.OTC: BTAIQ | Life Sciences | $344K | 1 | DivestitureOct 30, 2026 |
| 4129 | Cero Therapeutics Holdings, Inc.OTC: CERO | Life Sciences | $342K | 2 | Financial ResultsNov 13, 2026 |
| 4132 | Bioadaptives, Inc.OTC: BDPT | Life Sciences | $280K | 1 | M&A DealNov 4, 2026 |
| 4141 | Green Planet Bio Engineering Co. Ltd.OTC: GPLB | Life Sciences | $200K | 1 | Financial ResultsNov 13, 2026 |
| 4147 | Regen BioPharma IncOTC: RGBP | Life Sciences | $168K | 1 | Capital RaiseNov 2, 2026 |
| 4150 | Cnbx Pharmaceuticals Inc.OTC: CNBX | Life Sciences | $161K | 1 | Other 8-K FilingOct 1, 2026 |
| 4155 | Petros Pharmaceuticals, Inc.OTC: PTPI | Life Sciences | $110K | 1 | Bankruptcy & RestructuringSep 30, 2026 |
| 4167 | Synergy CHC Corp.OTC: SNYRQ | Life Sciences | $2.26K | 1 | Nasdaq/NYSE Compliance NoticeSep 16, 2026 |
| 4168 | Aditxt, Inc.OTC: ADTX | Life Sciences | $326 | 2 | Deal TerminationOct 15, 2026 |
| 4204 | Curaleaf Holdings, Inc.OTC: CURLF | Life Sciences | — | 14 | M&A DealNov 10, 2026 |
| 4215 | Regeneron Pharmaceuticals, Inc.NASDAQ: REGN | Life Sciences | — | 13 | Insider SellingNov 6, 2026 |
| 4223 | Jaguar Health, Inc.NASDAQ: JAGX | Life Sciences | — | 12 | Financial ResultsNov 16, 2026 |